Portfolio company
ACET
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Adicet Bio develops allogeneic gamma delta T cell therapies for patients with autoimmune diseases and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Adicet Bio
Adicet Bio develops allogeneic gamma delta T cell therapies for patients with autoimmune diseases and cancer.
ARTV
This clinical-stage biotechnology company develops natural killer cell therapies for patients with autoimmune diseases and cancers.
Allogene Therapeutics
The company develops off-the-shelf allogeneic CAR T-cell therapies for patients with blood cancers, solid tumours and autoimmune diseases.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
Appia Bio
This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.
Cabaletta Bio
This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.
LAVA Therapeutics
The company develops bispecific antibodies that engage gamma-delta T cells to treat hematological and solid cancers.
Artiva Biotherapeutics
The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.